Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A genetic association study

The Lancet

Volumn 387, Issue 10014, 2016, Pages 156-167

  Cleynen, Isabelle ^a,b   Boucher, Gabrielle ^c   Jostins, Luke ^a,d,e   Schumm, L Philip ^f   Zeissig, Sebastian ^g   Ahmad, Tariq ^h   Andersen, Vibeke ^i,j   Andrews, Jane M ^k,l   Annese, Vito ^m,n   Brand, Stephan ^o   Brant, Steven R ^p,q   Cho, Judy H ^r   Daly, Mark J ^s   Dubinsky, Marla ^u   Duerr, Richard H ^v,w   Ferguson, Lynnette R ^x   Franke, Andre ^g   Gearry, Richard B ^y,z   Goyette, Philippe ^c   Hakonarson, Hakon ^aa   Halfvarson, Jonas ^ab,ac   Hov, Johannes R ^ad   Huang, Hailang ^t   Kennedy, Nicholas A ^ad   Kupcinskas, Limas ^af,ag   Lawrance, Ian C ^ah,ai   Lee, James C ^aj   Satsangi, Jack ^ad   Schreiber, Stephan ^g,h   Théâtre, Emilie ^ak,al   Van Der Meulen De Jong, Andrea E ^am   Weersma, Rinse K ^an   Wilson, David C ^ae,ao   Parkes, Miles ^aj   Vermeire, Severine ^b,ap   Rioux, John D ^c   Mansfield, John ^aq   Silverberg, Mark S ^t   Radford Smith, Graham ^t   McGovern, Dermot P B ^t   Barrett, Jeffrey C ^a   Lees, Charlie W ^ad   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e CHRIST CHURCH   (United Kingdom)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF KIEL   (Germany)

^h PENINSULA MEDICAL SCHOOL   (United Kingdom)

ⁱ VIBORG HOSPITAL   (Denmark)

^j Hospital of Southern Jutland   (Denmark)

^k ROYAL ADELAIDE HOSPITAL   (Australia)

^l UNIVERSITY OF ADELAIDE   (Australia)

^m CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁿ CAREGGI UNIVERSITY HOSPITAL   (Italy)

^o LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^r YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^t CEDARS SINAI MEDICAL CENTER   (United States)

^u UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^w UNIVERSITY OF AUCKLAND   (New Zealand)

^x UNIVERSITY OF OTAGO   (New Zealand)

^y CHRISTCHURCH HOSPITAL   (New Zealand)

^z CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^aa Örebro University   (Sweden)

^ab ÖREBRO UNIVERSITY   (Sweden)

^ac UNIVERSITY OF OSLO   (Norway)

^ad UNIVERSITY OF EDINBURGH   (United Kingdom)

^ae LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^af UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^ag UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ah UNIVERSITY OF LIÈGE   (Belgium)

^ai UNIVERSITY OF LIÈGE   (Belgium)

^aj LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ak UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^al ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^am UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^an NEWCASTLE UNIVERSITY   (United Kingdom)

^ao UNIVERSITY OF TORONTO   (Canada)

^ap QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^aq UNIVERSITY OF QUEENSLAND   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; HLA DRB1 ANTIGEN; MACROPHAGE STIMULATING PROTEIN; NOD2 PROTEIN, HUMAN; ONCOPROTEIN; SCATTER FACTOR;

ADULT; ARTICLE; CROHN DISEASE; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MHC GENE; MST1 GENE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ALLELE; CLINICAL TRIAL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOASSAY; MULTICENTER STUDY; RISK ASSESSMENT; YOUNG ADULT;

ADULT; ALLELES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATOCYTE GROWTH FACTOR; HLA-DRB1 CHAINS; HUMANS; IMMUNOASSAY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RISK ASSESSMENT; YOUNG ADULT;

EID: 84954077730     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00465-1     Document Type: Article

References (47)

1. NA Molodecky, IS Soon, DM Rabi et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54 e42.
2. M Neovius, EV Arkema, P Blomqvist et al. Patients with ulcerative colitis miss more days of work than the general population, even following colectomy Gastroenterology 144 2013 536 543
3. JE Everhart, CE Ruhl Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases Gastroenterology 136 2009 376 386
4. B Khor, A Gardet, RJ Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
5. BS Kirschner Ulcerative colitis in children Pediatr Clin North Am 43 1996 235 254
6. B Moum, A Ekbom, MH Vatn et al. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway Gut 40 1997 328 332
7. A Pera, P Bellando, D Caldera et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score Gastroenterology 92 1987 181 185
8. J Satsangi, MS Silverberg, S Vermeire et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications Gut 55 2006 749 753
9. MS Silverberg, J Satsangi, T Ahmad et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 suppl A 2005 5 36
10. BB Crohn, L Ginzburg, GD Oppenheimer Regional ileitis; a pathologic and clinical entity JAMA 99 1932 1323 1329
11. TK Dalziel Thomas Kennedy Dalziel 1861-1924. Chronic interstitial enteritis Dis Colon Rectum 32 1989 1076 1078
12. MS Silverberg, L Mirea, SB Bull et al. A population- and family-based study of Canadian families reveals association of HLA DRB1∗0103 with colonic involvement in inflammatory bowel disease Inflamm Bowel Dis 9 2003 1 9
13. AP Cuthbert, SA Fisher, MM Mirza et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease Gastroenterology 122 2002 867 874
14. T Ahmad, A Armuzzi, M Bunce et al. The molecular classification of the clinical manifestations of Crohn's disease Gastroenterology 122 2002 854 866
15. SR Brant, MF Picco, JP Achkar et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes Inflamm Bowel Dis 9 2003 281 289
16. I Cleynen, JR Gonzalez, C Figueroa et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project Gut 62 2013 1556 1565
17. EG de la Concha, M Fernandez-Arquero, G Lopez-Nava et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL Gastroenterology 119 2000 1491 1495
18. M Economou, TA Trikalinos, KT Loizou, EV Tsianos, JPA Ioannidis Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a meta analysis Am J Gastroenterol 99 2004 2393 2404
19. B Newman, MS Silverberg, X Gu et al. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease Am J Gastroenterol 99 2004 306 315
20. A Dignass, JO Lindsay, A Sturm et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management J Crohns Colitis 6 2012 991 1030
21. A Dignass, G Van Assche, JO Lindsay et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management J Crohns Colitis 4 2010 28 62
22. C Mowat, A Cole, A Windsor et al. Guidelines for the management of inflammatory bowel disease in adults Gut 60 2011 571 607
23. SB Hanauer, BG Feagan, GR Lichtenstein et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 2002 1541 1549
24. SB Hanauer, WJ Sandborn, P Rutgeerts et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial Gastroenterology 130 2006 323 333
25. W Reinisch, WJ Sandborn, DW Hommes et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Gut 60 2011 780 787
26. P Rutgeerts, WJ Sandborn, BG Feagan et al. Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
27. WJ Sandborn, G van Assche, W Reinisch et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis Gastroenterology 142 2012 257 265 e1-3.
28. BG Feagan, P Rutgeerts, BE Sands et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis N Engl J Med 369 2013 699 710
29. WJ Sandborn, BG Feagan, P Rutgeerts et al. Vedolizumab as induction and maintenance therapy for Crohn's disease N Engl J Med 369 2013 711 721
30. AD Frolkis, J Dykeman, ME Negron et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies Gastroenterology 145 2013 996 1006
31. IC Solberg, I Lygren, J Jahnsen et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) Scand J Gastroenterol 44 2009 431 440
32. IC Solberg, MH Vatn, O Hoie et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study Clin Gastroenterol Hepatol 5 2007 1430 1438
33. L Jostins, S Ripke, RK Weersma et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
34. JE Lennard-Jones Classification of inflammatory bowel disease Scand J Gastroenterol Suppl 170 1989 2 6 discussion 16-19.
35. P Goyette, G Boucher, D Mallon et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis Nat Genet 7 2015 172 179
36. S Purcell, B Neale, K Todd-Brown et al. PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
37. L Jostins, AP Levine, JC Barrett Using genetic prediction from known complex disease loci to guide the design of next-generation sequencing experiments PLoS One 8 2013 e76328
38. JC Barrett, S Hansoul, DL Nicolae et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat Genet 40 2008 955 962
39. WA Faubion Jr, EV Loftus Jr, WS Harmsen et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study Gastroenterology 121 2001 255 260
40. J Halfvarson, L Bodin, C Tysk et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics Gastroenterology 124 2003 1767 1773
41. L Henckaerts, K Van Steen, I Verstreken et al. Genetic risk profiling and prediction of disease course in Crohn's disease patients Clin Gastroenterol Hepatol 7 2009 972 980 e2.
42. PT Donaldson, JM Farrant, ML Wilkinson et al. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis Hepatology 13 1991 129 133
43. A Spurkland, S Saarinen, KM Boberg et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations Tissue Antigens 53 1999 459 469
44. EV Loftus Jr, GC Harewood, CG Loftus et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 2005 91 96
45. ML Hamshere, MC O'Donovan, IR Jones et al. Polygenic dissection of the bipolar phenotype Br J Psychiatry 198 2011 284 288
46. GB Chen, SH Lee, MJ Brion et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data Hum Mol Genet 23 2014 4710 4720
47. XC Morgan, TL Tickle, H Sokol et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment Genome Biol 13 2012 R79